Resultados de búsqueda - Provan, Sella A
- Mostrando 1 - 11 Resultados de 11
-
1
The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis por Provan, Sella A, Dean, Linda E, Jones, Gareth T, Macfarlane, Gary J
Publicado 2021Texto -
2
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during bi... por Hammer, Hilde Berner, Michelsen, Brigitte, Sexton, Joe, Uhlig, Till, Provan, Sella A.
Publicado 2020Texto -
3
The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study por Provan, Sella A, Angel, Kristin, Ødegård, Sigrid, Mowinckel, Petter, Atar, Dan, Kvien, Tore K
Publicado 2008Texto -
4
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study por Angel, Kristin, Provan, Sella A., Fagerhol, Magne K., Mowinckel, Petter, Kvien, Tore K., Atar, Dan
Publicado 2012Texto -
5
Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study por Christensen, Ingrid Egeland, Lillegraven, Siri, Mielnik, Pawel, Bakland, Gunnstein, Loli, Liz, Sexton, Joe, Uhlig, Till, Kvien, Tore K, Provan, Sella A
Publicado 2022Texto -
6
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries por Delcoigne, Benedicte, Ljung, Lotta, Provan, Sella A, Glintborg, Bente, Hetland, Merete Lund, Grøn, Kathrine Lederballe, Peltomaa, Ritva, Relas, Heikki, Turesson, Carl, Gudbjornsson, Bjorn, Michelsen, Brigitte, Askling, Johan
Publicado 2022Texto -
7
Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis por Maehlen, Marthe T., Provan, Sella A., de Rooy, Diederik P. C., van der Helm - van Mil, Annette H. M., Krabben, Annemarie, Saxne, Tore, Lindqvist, Elisabet, Semb, Anne Grete, Uhlig, Till, van der Heijde, Désirée, Mero, Inger Lise, Olsen, Inge C., Kvien, Tore K., Lie, Benedicte A.
Publicado 2013Texto -
8
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example por Chatzidionysiou, Katerina, Hetland, Merete Lund, Frisell, Thomas, Di Giuseppe, Daniela, Hellgren, Karin, Glintborg, Bente, Nordström, Dan, Aaltonen, Kalle, Törmänen, Minna RK, Klami Kristianslund, Eirik, Kvien, Tore K, Provan, Sella A, Guðbjörnsson, Bjorn, Dreyer, Lene, Kristensen, Lars Erik, Jørgensen, Tanja Schjødt, Jacobsson, Lennart, Askling, Johan
Publicado 2018Texto -
9
Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy por Syversen, Silje W., Jyssum, Ingrid, Tveter, Anne T., Tran, Trung T., Sexton, Joseph, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Grødeland, Gunnveig, Nissen‐Meyer, Lise S. H., Ricanek, Petr, Chopra, Adity, Andersson, Ane M., Kro, Grete B., Jahnsen, Jørgen, Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T., Lund‐Johansen, Fridtjof, Jørgensen, Kristin K., Goll, Guro L.
Publicado 2022Texto -
10
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study por Jyssum, Ingrid, Kared, Hassen, Tran, Trung T, Tveter, Anne T, Provan, Sella A, Sexton, Joseph, Jørgensen, Kristin K, Jahnsen, Jørgen, Kro, Grete B, Warren, David J, Vaage, Eline B, Kvien, Tore K, Nissen-Meyer, Lise-Sofie H, Anderson, Ane Marie, Grødeland, Gunnveig, Haavardsholm, Espen A, Vaage, John Torgils, Mjaaland, Siri, Syversen, Silje Watterdal, Lund-Johansen, Fridtjof, Munthe, Ludvig A, Goll, Guro Løvik
Publicado 2022Texto -
11
Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY por Joergensen, Kristin K., Syversen, Silje W, Jyssum, ingrid, Tveter, Anne Therese, Tran, Trung T., Sexton, Joe, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Gr⊘deland, Gunnveig, Nissen-Meyer, Lise Sofie H., Ricanek, Petr, Chopra, Adity, Anderson, Ane M., Kro, Grete B., Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T.T., Lund-Johansen, Fridtjof, Jahnsen, Jorgen, Goll, Guro L.
Publicado 2022Texto